For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

CRISPR Therapy Significantly Reduces LDL Cholesterol in Clinical Trial

Oct 1, 2026
CRISPR Therapy Significantly Reduces LDL Cholesterol in Clinical Trial

A first-in-human Phase 1 clinical trial conducted by Cleveland Clinic has shown that a single infusion of the CRISPR-Cas9 gene-editing therapy, known as CTX310, can produce lasting reductions in LDL cholesterol and triglycerides in individuals suffering from lipid disorders that have not responded adequately to existing medications. This study involved 15 patients and aimed to assess whether the cholesterol and triglyceride reductions observed after two months would persist over a longer duration. Remarkably, after a 12-month follow-up, participants who received the highest dose of CTX310 exhibited a 52.5% reduction in LDL cholesterol levels and a 47.8% decrease in triglycerides compared to their baseline measurements. Importantly, throughout the one-year follow-up, no serious adverse events related to the therapy were reported, indicating a favorable safety profile. These findings were presented at the 2026 European Society of Cardiology annual meeting and were simultaneously published in the New England Journal of Medicine. Dr. Luke Laffin, a cardiologist at Cleveland Clinic and the first author of the study, expressed optimism about the results, stating, "The durability of the lipid-lowering effect was impressive," and noted the absence of serious safety events associated with CTX310 during the trial and the subsequent year. The CRISPR-Cas9 technology employed in this experimental treatment is designed to make targeted alterations to specific regions of a person's DNA, and researchers are exploring its potential to address serious diseases by modifying genes that contribute to these conditions. The CTX310 treatment is administered as a one-time infusion, delivering the CRISPR editing system directly to the liver, where it functions to deactivate a gene known as ANGPTL3. This gene plays a crucial role in regulating fats present in the bloodstream, and its inhibition can lead to reductions in both LDL cholesterol and triglycerides, which are linked to cardiovascular disease. During the trial, patients received varying doses of CTX310, ranging from 0.1 to 0.8 mg/kg, and were pre-treated with corticosteroids and antihistamines to mitigate potential side effects. Researchers monitored the participants for safety and measured changes in ANGPTL3, LDL cholesterol, and triglyceride levels. At the highest dose, the therapy resulted in an average reduction of about 50% in both LDL cholesterol and triglycerides 12 months post-treatment. While these preliminary results are encouraging, it is important to note that CTX310 remains an experimental therapy, and the study involved a limited number of participants. The researchers plan to continue long-term safety follow-up for an additional 15 years, in accordance with FDA recommendations for gene-editing therapies. The study was funded by CRISPR Therapeutics AG, based in Zug, Switzerland, and Dr. Laffin's institution has received research funding from the same company.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)